An experimental evaluation of the anti-atherogenic potential of the plant, Piper betle, and its active constitutent, eugenol, in rats fed an atherogenic diet

Biomedicine and Pharmacotherapy

Volumn 80, Issue , 2016, Pages 276-288

  Venkadeswaran, Karuppasamy ^a   Thomas, Philip A ^b   Geraldine, Pitchairaj ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b JOSEPH EYE HOSPITAL   (India)

Author keywords

Antioxidant; Atherogenic diet; Atherosclerosis; Eugenol; Oxidative stress; Piper betle

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BETEL EXTRACT; CATALASE; CHOLESTEROL; EUGENOL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LACTATE DEHYDROGENASE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIATHEROGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; AORTIC TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME BLOOD LEVEL; HEART PROTECTION; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LIVER PROTECTION; MALE; NONHUMAN; PIPER BETLE; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; FEEDING BEHAVIOR; METABOLISM; PATHOLOGY; PHYTOTHERAPY; THORACIC AORTA; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; ATHEROSCLEROSIS; BIOMARKERS; CHOLESTEROL; DIET, ATHEROGENIC; EUGENOL; FEEDING BEHAVIOR; LIVER; MALE; MALONDIALDEHYDE; PHYTOTHERAPY; PIPER BETLE; RATS, WISTAR;

EID: 84961899513     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.03.028     Document Type: Article

References (94)

1. Prasad K., Kalra J. Oxygen-free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am. Heart J. 1993, 125:958-973.
2. Deepa P.R., Varalakshmi P. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin. Chim. Acta 2004, 339:105-115.
3. Yu-Poth S., Zhao G., Etherton T., Naglak M., Jonnalagadda S., Kris-Etherton P.M. Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am. J. Clin. Nutr. 1999, 69:632-646.
4. Leys D., Deplanque D., Mounier-Vehier C., Mackowiak-Cordoliani M.A., Lucas C., Bordet R. Stroke prevention: management of modifiable vascular risk factors. J. Neurol. 2002, 249:507-517.
5. Griendling K.K., Harrison D.G. Dual role of reactive oxygen species in vascular growth. Circ. Res. 1999, 85:562-563.
6. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
7. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003, 91:7-11.
8. De Meyer G.R., Herman A.G. Vascular endothelial dysfunction. Prog. Cardiovasc. Dis. 1997, 39:325-342.
9. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
10. Bocan T.M. Animal models of atherosclerosis and interpretation of drug intervention studies. Curr. Pharm. Des. 1998, 4:37-52.
11. Bulur H., Ozdemirler G., Oz B., Toker G., Ozturk M., Uysal M. High cholesterol diet supplemented with sunflower seed oil but not olive oil stimulates lipid peroxidation in plasma, liver, and aorta of rats. J. Nutr. Biochem. 1995, 6:547-550.
12. Ramesh E., Elanchezhian R., Sakthivel M., Jayakumar T., Senthil Kumar R.S., Geraldine P., Thomas P.A. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam. Clin. Pharmacol. 2008, 22:275-284.
13. Anandhi R., Thomas P.A., Geraldine P. Evaluation of the anti-atherogenic potential of chrysin in Wistar rats. Mol. Cell. Biochem. 2014, 385:103-113.
14. Shi W.B., Haberland M.E., Jien M.L., Shih D.M., Lusis A.J. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 2000, 102:75-81.
15. Koff R.S., Gordan G., Sabesin S.M. D-Galactosamine hepatitis hepatocellular injury and fatty liver following a single dose. Proc. Soc. Exp. Biol. Med. 1971, 137:696-701.
16. P. Maisuthisakul, Phenolic Constituents and Antioxidant Properties of some Thai Plants. Phytochemicals-A Global Perspective of Their Role in Nutrition and Health 2007.
17. Venkadeswaran K., Muralidharan A.R., Annadurai T., VasanthaRuban V., Sundararajan M., Anandhi R., Thomas P.A., Geraldine P. Antihypercholesterolemic and antioxidative potential of an extract of the plant, Piper betle, and its active constituent, eugenol, in triton WR-1339-induced hypercholesterolemia in experimental rats. Evid. Based Complement. Alternat. Med. 2014, 47897:3. 10.1155/2014/478973.Epub2014Jan9.
18. Widowati W., Mozef T., Risdian C., Yellianty Anticancer and free radical scavenging potency of Catharanthus roseus, Dendrophthoe petandra, Piper betle and Curcuma mangga extracts in breast cancer cell lines. Oxid. Antioxid. Med. Sci. 2013, 2(2):137-142.
19. Kanjwani D.G., Marathe T.P., Chiplunkar S.V., Sathaye S.S. Evaluation of immunomodulatory activity of methanolic extract of Piper betle. Scand. J. Immunol. 2008, 67:589-593.
20. Ghosh R., Darin K., Panchali P.Nath An overview of various Piper species for their biological activities. Int. J. Pharma Res. Rev. 2014, 3(January (1)):67-75.
21. Sharma J.D., Sharma L., Yadav P. Antifertility efficacy of Piper betle linn: (Petiole) on female albino rats. Asian J. Exp. Sci. 2007, 21(1):145-150.
22. Bhattacharya S.S., Mula S., Gamre J.P., Kamat S.K., Bandyopadhyay Chattopadhyay S. Inhibitory property of Piper betle extract against photosensitization-induced damages to lipids and protein. Food Chem. 2006, 147:4-1480.
23. Wirotesangthong M., Inagaki N., Tanaka H., Thanakijcharoenpatha W., Nagai H. Inhibitory effects of Piper betle on production of allergic mediators by bone marrow-derived mast cells and lung epithelial cells. Int. Immunopharmacol. 2008, 8(3):453-457.
24. Arambewela L.S.R., Arawwawala L.D.A.M., Ratnasooriya W.D. Gastro protective activities of Sri Lankan Piper betle leaf extracts in rats. SLAAS. 60th Annual Session 2004, 117.
25. Arambewela L.S.R., LDAM Arawwawala, Kumaratunga K.G., Dissanayake D.S., Ratnasooriya W.D., Kumarasingha S.P. Investigations on Piper betle grown in Sri Lanka. Pharmacogn. Rev. 2011, 5(10):159-163.
26. Nilugal K.C., Perumal K., Ugander R.E., Chittor A.I. Evaluation of wound healing activity of Piper betle leaves and stem extract in experimental Wistar rats. Am. J. PharmTech Res. 2014, 4(3):276-289.
27. Misra K.H., Kodanda Ramu B., Ranjita N., Bandyopadhyay M. Evaluation of antiasthmatic effect of ethanol extract of Piper betle linn. Against histamine induced Bronchospasm in guinea pigs. Int. J. Basic Appl. Chem. Sci. 2014, 4(1):67-73.
28. Shun C.Y., Chau J.W., Jing J.L., Pei L.P., Jui L.H., Fen P.C. Protection effect of Piper betle leaf extract against carbon tetrachloride induced liver fibrosis in rats. Arch. Toxicol. 2007, 81:45-55.
29. Ito M., Murakami K., Yoshino M. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem. Toxicol. 2005, 43:461-466.
30. Kabuto H., Tada M., Eugenol Kohno M. [2-methoxy-4-(2-propenyl) phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol. Pharm. Bull. 2007, 30:423-427.
31. Morsy M.A., Fouad A.A. Mechanisms of gastro protective effect of eugenol in indomethacin-induced ulcer in rats. Phytother. Res. 2008, 22:1361-1366.
32. Dodge J.T., Mitchell C., Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 1963, 100:119-130.
33. Quist E.E. Regulation of erythrocyte membrane shape by Ca2+. Biochem. Biophys. Res. Commun. 1980, 92:631-637.
34. Bradford M.A. Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
35. Nauk M., Wiebe D., Warnick G. Measurement of high-density-lipoprotein cholesterol. Handbook of Lipoprotein Testing 2000, 221-244. Amer. Assoc. for Clinical Chemistry (AACC press), City. 2nd edition. N. Rifai, G. Warnick, M. Dominiczak (Eds.).
36. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983, 29(3):538-542.
37. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
38. Grove T.H. Effect of reagent pH on determination of high density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clin. Chem. 1979, 25:560-564.
39. Burstein M., Scholnick H.R., Mortin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polvanions. Scand. J. Clin. Lab. Invest. 1980, 40:583-595.
40. Baginsky M.L. Measurement of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma. Methods Enzymol. 1981, 72:325-338.
41. Rao A.V., Ramakrishnan S. Indirect assessment of hydroxymethylglutaryl- CoA reductase (NADPH) activity in liver tissue. Clin. Chem. 1975, 21:1523-1525.
42. King J. The transferases-alanine and aspartate transaminases. Practical Clinical Enzymology 1965, 121-138. Nostrand, London, UK. D. Van (Ed.).
43. King J. The hydrolases-acid and alkaline phosphatises. Practical Clinical Enzymology 1965, 191-208. Nostrand, London, UK. D. Van (Ed.).
44. King J. The dehydrogenases or oxidoreductases lactate dehydrogenase. Practical Clinical Enzymology 1965, 83-93. Nostrand, London, UK. D. Van (Ed.).
45. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47:469-474.
46. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 1972, 47:389-394.
47. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.C., Hoekstra, Selenium W.G. Biochemical role as a component of glatathione peroxidase. Science 1973, 179:588-590.
48. Habig W.H., Jakoby W.B. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 1981, 77:398-405.
49. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 1979, 582:67-78.
50. Omaye S.T., David Turnbull J., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 1979, 62:3-11.
51. Desai I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol. 1984, 105:138-147.
52. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
53. Drury R.A.B., Wallington E.A. Carleton's Histological Technique 1980, Oxford University Press, New York, NY, USA.
54. Kutuk O., Basaga H. Inflammation meets oxidation: nF-kB as a mediator of initial lesion development in atherosclerosis. Trends Mol. Med. 2003, 9:549-557.
55. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk 1996, 3:213-219.
56. Malloy M.J., Kane J.D. Medical management of hyperlipidemic states. Adv. Intern. Med. 1994, 39:603-631.
57. Harnafi H., Serghini Caid H., Houda Bouanani N., Aziz M., Amrani S. Hypolipemic activity of polyphenol-rich extracts from Ocimumbasilicum in Triton WR-1339-induced hyperlipidemic mice. Food Chem. 2008, 108:205-212.
58. Shah P.K. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol. Clin. 1999, 17:271-281.
59. Yadav S.K., Sehgal S. Effect of home processing and storage on ascorbic acid and beta-carotene content of Bathua (Chenopodium album) and fenugreek (Trigonellafoenumgraecum) leaves. Plant Foods Hum. Nutr. 1997, 50:239-247.
60. Chakraborty D., Shah B. Antimicrobial anti-oxidative and anti-hemolytic activity of Piper betel leaf extracts. Int. J. Pharm. Pharm. Sci. 2011, 3:192-199.
61. Langmead L., Dawson C., Hawkins C., Banna N., Loo S., Rampton D.S. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment. Pharmacol. Ther. 2002, 16:197-205.
62. Devasena T., Menon V.P. Enhancement of circulatoryantioxidants by fenugreek during 1,2-dimethylhydrazine induced rat colon carcinogenesis. J. Biochem. Mol. Biol. Biophys. 2002, 6:289-292.
63. Devasena T., Menon V.P. Fenugreek seeds modulate1, 2-dimethylhydrazine-induced hepatic oxidative stress during colon carcinogenesis. Ital. J. Biochem. 2007, 56:28-34.
64. Belguith-Hadriche O., Bouaziz M., Jamoussi K.E., Feki A., Sayadi S., Makni-Ayedi F. Lipid-lowering and antioxidant effects of ethyl acetate extract of fenugreek seeds in high-cholesterol-fed rats. J. Agric. Food Chem. 2010, 58:2116-2122.
65. Mollica M.P., Iossa S., Liverini G., Soboll S. Stimulation of oxygen consumption following addition of lipid substrates in liver and skeletal muscle from rats fed a high-fat diet. Metabolis 1999, 48:1230-1235.
66. Pedersen T.R., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman G. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) 1994. Atheroscler. Suppl. 2004, 5:81-87.
67. Bensadoun A. Lipoprotein lipase. Annu. Rev. Nutr. 1991, 11:217-237.
68. Reymer P.W., Groennemeyer B.E., Gagne E., Miao L., Appelman E.E., Seidel J.C., Krombout D., Bijvoet S.M., van de K., Oever K.T., Bruin A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 1995, 4:1543-1549.
69. Kavitha R., Nalini N. Hypolipidemic effect of green and red chilli extract in rats fed high fat diet. Med. Sci. Res. 2000, 28:17-21.
70. Sudhahar V., Kumar S.A., Varalakshmi P. Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sci. 2006, 78:1329-1335.
71. Visavadiya N.P., Narasimhacharya A.V. Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats. Evid. Based Complement. Alternat. Med. 2009, 6:219-226.
72. Vijayakumar R.S., Nalini N. Lipid-lowering efficacy of piperine from Piper nigrum L. in high-fat diet and anti thyroid drug-induced hypercholesterolemic rats. J. Food Biochem. 2006, 30:405-421.
73. Kleemann R., Kooistra T. HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5:441-453.
74. Shimada M., Ishibashi S., Inaba T., Yagyu H., Harada K., Osuga J.I., Ohashi K., Yazaki Y., Yamada N. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice over expressing lipoprotein lipase. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7242-7246.
75. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 1994, 344:793-795.
76. Chait A., Brazg R.L., Tribble D.L., Krauss R.M. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 1993, 94:350-356.
77. Davi G., Alessandrini P., Mezzetti A. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 1997, 17:3230-3235.
78. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 1994, 344:793-795.
79. Kuçukgergin C., AydIn A.F., Ozdemirler-Erata G., Mehmetçik N., Koçak- Toker G., Uysal M. Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biol. Trace Elem. Res. 2010, 135:264-274.
80. Molander D.W., Wroblewski F., Ladue J.S. Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity. J. Lab. Clin. Med. 1955, 6:831-839.
81. Sheela C.G., Angusti K. Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn and gugulipid in cholesterol diet fed rats. Indian J. Exp. Biol. 1995, 33:337-341.
82. Fujisawa S., Atsumi T., Kadoma Y., Sakagami H. Antioxidant and pro-oxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 2002, 177:139-154.
83. Parasakthy K., Shanthi S., Deepalokshmi P., Niranjali S.D. The antioxidant effect of eugenol and carbon tetrachloride induced erythrocyte damage in rats. J. Nutr. Biochem. 1996, 7:23-28.
84. Gruenwald J., Brendler T., Jaenicke C. PDR for Herbal Medicines 2004, 245-246. Medical Economics Company, New Jersey. 3rd edition.
85. Komosinska-Vassev K., Olczyk K., Kucharz E.J., Marcisz C., Winsz-Szczotka K.A., Kotulska A. Free radical activity and antioxidant defence mechanisms patients with hyperthyroidism due to Graves disease during therapy. Clin. Chim. Acta 2000, 300:107-117.
86. Seven R., Gelisgen R., Seven A., Erbil Y., Bozbora A., Burcak G. Influe of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients. J. Toxicol. Environ. Health A 2001, 62:495-503.
87. Klaassen C.D., Bracken W.M., Dudley R.E., Goering P.L., Hazelton G.A., Hjelle J.J. Role of sulfhydryls in the hepatotoxicity of organic and metallic compounds. Toxicol. Sci. 1985, 5:806-815.
88. Janero J.R. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Radical Biol. Med. 1991, 11:129-144.
89. Verlangieri A.J., Bush M.J. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 1992, 11:131-138.
90. Freeman B.A., Crapo J.D. Biology of disease: free radicals and tissue injury. Lab. Invest. 1982, 47:412-426.
91. Niki E., Shimasaki H., Mino M. Antioxidant-Free Radical and Biological Defence 1994, Gakkai-Shuppan Center, Tokyo, Japan.
92. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward. Cardiovasc. Res. 2000, 47:410-418.
93. Mitani H., Egashira K., Kimura M. HMG-CoA-reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits. Pharmacol. Res. 2003, 48:417-427.
94. Al-Hamdany M.Z., Al-Hubaity A.Y. The histological and histochemical changes of the rat's liver induced by 5-fluorouracil. Iraqi J. Vet. Sci. 2014, 28(2):35-103.